Advances in Chronic Kidney Disease
Volume 17, Issue 4 , Pages 329-340 , July 2010

Epidemiology of Hypertension in the Elderly With Chronic Kidney Disease

  • Michael J. Fischer

      Affiliations

    • Corresponding Author InformationAddress correspondence to Michael J. Fischer, MD, MSPH, Center for Management of Complex Chronic Care, Hines VA Hospital and Jesse Brown VAMC, 5000 S. 5th Ave (151H), Hines, IL 60141.
    • ,
  • Ann M. O'Hare

References 

  1. United States Census Bureau: Available at: www.census.gov/
  2. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Int Med. 2002;162:2269–2276
  3. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
  4. O'Hare AM, Bertenthal D, Covinsky KE, et al. Mortality risk stratification in chronic kidney disease: One size for all ages?. J Am Soc Nephrol. 2006;17:846–853
  5. U.S. Renal Data System. USRDS 2009: Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2009;
  6. Kurella M, Covinsky KE, Collins AJ, et al. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med. 2007;146:177–183
  7. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305–313
  8. Barker WH, Mullooly JP, Linton KL. Trends in hypertension prevalence, treatment, and control in a well defined older population. Hypertension. 1998;31(1 Pt 2):552–559
  9. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308–315
  10. Hajjar I, Kotchen TA. Trend in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199–206
  11. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure: Less of one, more the other?. Am J Hypertens. 1988;1:335–347
  12. Cowley AW, Roman RJ. The role of the kidney in hypertension. JAMA. 1996;275:1581–1589
  13. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest. 1986;77:1993–2000
  14. Law CM, deSwiet M, Osmond C, et al. Initiation of hypertension in utero and its amplification throughout life. BMJ. 1993;306:24–27
  15. Keller G, Zimmer G, Mall G, et al. Nephron number in patients with primary hypertension. N Engl J Med. 2003;348:101–108
  16. Kestenbaum B, Rudser KD, deBoer IH, et al. Differences in kidney function and incident hypertension: The multi-ethnic study of atherosclerosis. Ann Intern Med. 2008;148:501–508
  17. Hsu CY, McCulloch CE, Darbinian J, et al. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med. 2005;165:923–928
  18. Zhou XJ, Rakheja D, Yu X, et al. The aging kidney. Kidney Int. 2008;74:710–720
  19. Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med. 2001;161:1207–1216
  20. Rao MV, Qui Y, Wang C, et al. Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004. Am J Kidney Dis. 2008;51(Suppl 2):S30–S37
  21. Kalaitzidis R, Li S, Wang C, et al. Hypertension in early-stage kidney disease: An update from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2009;53(Suppl 4):S22–S31
  22. Ostchega Y, Dillon CF, Hughes JP, et al. Trends in Hypertension prevalence, awareness, treatment, and control in older U.S. adults: Data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc. 2007;55:1056–1065
  23. Roderick PJ, Atkins RJ, Smeeth L, et al. CKD and mortality risk in older people: A community-based population study in the United Kingdom. Am J Kidney Dis. 2009;53:950–960
  24. Peralta CA, Hicks LS, Chertow GM, et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension. 2005;45:1119–1124
  25. Plantinga LC, Miller ER, Stevens LA, et al. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999 to 2006. Hypertension. 2009;54:47–56
  26. Sarafidis PA, Li S, Chen SC, et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med. 2008;121:332–340
  27. Borzecki AM, Wong AT, Hickey EC, et al. Hypertension control: How well are we doing?. Arch Intern Med. 2003;163:2705–2711
  28. Peralta CA, Shlipak MG, Wassel-Fyr C, et al. Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. Hypertension. 2007;50:474–480
  29. Somes GW, Pahor M, Shorr RI, et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med. 1999;159:2004–2009
  30. Fagard RH, Staessen JA, Thijs I, et al. On treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med. 2007;167:1884–1891
  31. Messerli FH, Mancia G, Conti R, et al. Dogma disputed: Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous. Ann Intern Med. 2006;144:884–893
  32. Investigators ONTARGET. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:52–61
  33. Hyman DJ. Pavlik Van: Self-reported hypertension treatment practices among primary care physicians. Arch Intern Med. 2000;160:2281–2286
  34. Oliveria SA, Lapuerta P, McCarthy BD, et al. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413–420
  35. Hajjar I, Miller K, Hirth V. Age-related bias in the management of hypertension: A national survey of physicians' opinions on hypertension in elderly adults. J Gerontol. 2002;57:487–491
  36. SHEP Cooperative Research Group . Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in Elderly Program (SHEP). JAMA. 1997;265:3255–3264
  37. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, and evaluation and treatment of high blood pressure. Hypertension. 2003;42:1206–1252
  38. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for management of hypertension: Report of the fourth working party of British Hypertension Society, 2004–BHS IV. J Hum Hypertens. 2004;18:139–185
  39. Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 guidelines for the management of arterial hypertension. J Hypertens. 2007;25:1105–1187
  40. World Health Organization . 2003 World health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983–1992
  41. Canadian Hypertension Education Program . 2007 guidelines for the management of arterial hypertension. Can J Cardiol. 2007;23:539–559
  42. Zanchetti A, Grassi G, Mancia G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical appraisal. J Hypertens. 2009;27:923–934
  43. Zanchetti A, Mancia G, Black HR, et al. Facts and fallacies of blood pressure control in recent trials: Implications in the management of patients with hypertension. J Hypertens. 2009;27:673–679
  44. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–1898
  45. Lindemann RD. Hypertension and kidney protection in the elderly: What is the evidence in 2007?. Int Urol Nephrol. 2007;39:669–678
  46. Goodwin JS. Embracing complexity: A consideration of hypertension in the very old. J Gerontol. 2003;58:653–658
  47. Estacio RO, Jeffers BW, Hiatt WR, et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med. 1998;338:645–652
  48. Schrier RW, Estacio RO, Esler A, et al. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy, and strokes. Kidney Int. 2002;61:1086–1097
  49. Lewis JB, Berl T, Bain RP, et al. Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am J Kidney Dis. 1999;34:809–817
  50. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317:703–713
  51. Reggenenti P, Perna A, Loriga G, et al. Blood pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): Multicentre, randomized, controlled trial. Lancet. 2005;365:939–946
  52. Wright JT, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA. 2002;288:2421–2431
  53. Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med. 1994;330:877–884
  54. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, et al. Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant. 2006;21:1257–1262
  55. Agarwal R. Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:830–837
  56. The ACCORD Study Group: Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Eng J Med (in press)

 Support and Financial Disclosure Declaration: The authors received funding support for this research project from: Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service (VA HSR&D Career Development Award—M. Fischer) and the National Institutes of Health (K23AG28980—A. O'Hare). The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs or Health Services Research and Development Service.

PII: S1548-5595(10)00080-7

doi: 10.1053/j.ackd.2010.05.003

Advances in Chronic Kidney Disease
Volume 17, Issue 4 , Pages 329-340 , July 2010

Article Tools